Current Drug Discovery Technologies

Vladimir P. Torchilin
Department of Pharmaceutical Science Center
for Pharmaceutical Biotechnology and Nanomedicine
Northeastern University
Boston, MA 02115



Become EABM
Become Reviewer

The Oxazolomycins: A Structurally Novel Class of Bioactive Compounds

Volume:1   Issue: 3
Pp: 181-199
Mark G. Moloney, Paul C. Trippier, Muhammad Yaqoob and Zhaoyang Wang
DOI: 10.2174/1570163043334974

Efficient Optimization Strategy for Marginal Hits Active Against abl Tyrosine Kinases

Volume:1   Issue: 3
Pp: 201-210
Sergey E. Tkachenko, Ilya Okun, Konstantin V. Balakin, Charles E. Petersen, Yan A. Ivanenkov, Nikolay P. Savchuk and Andrey A. Ivashchenko
DOI: 10.2174/1570163043335018

Strategies for Compound Selection

Volume:1   Issue: 3
Pp: 211-220
Marius M. Olah, Cristian G. Bologa and Tudor I. Oprea
DOI: 10.2174/1570163043334965

Prediction of Glomerular Filtration Rate From Body Cell Mass and Plasma Creatinine

Volume:1   Issue: 3
Pp: 221-228
Carlo Donadio, Cristina Consani, Michela Ardini, Francesca Caprio, Giulia Grassi and Annalisa Lucchesi
DOI: 10.2174/1570163043334956

Applications of Multi-Angle Laser Light-Scattering Detection in the Analysis of Peptides and Proteins

Volume:1   Issue: 3
Pp: 229-242
Alexis Oliva, Matias Llabres and Jose B. Farina
DOI: 10.2174/1570163043334938